PRIME Journal Sep/Oct 2022
The latest issue of PRIME Journal is now available!
Read MoreThe latest issue of PRIME Journal is now available!
Read MoreGabriela Casabona shares her seven-step approach to treat skin laxity and restore volume to the...
Read MoreWendy Lewis investigates how to navigate the shortage of qualified employees while maintaining the customer experience
Read MoreIM-Aesthetics announces AMWC North America to be held on February 23–25, 2023
Read MoreReport aims to help support the evolving needs of patients
Read MoreRevelle Aesthetics, Inc. (Revelle) — a VC-backed Silicon Valley MedTech company — achieved an extended FDA clearance for its precision cellulite release device, Avéli™. Marking another key milestone for the Company, Avéli is now...
Read MoreRevance Therapeutics, Inc., a biotechnology company focused on innovative aesthetic and therapeutic offerings, announced that the U.S. Food and Drug Administration (FDA) has approved DAXXIFY™ (DaxibotulinumtoxinA-lanm) for...
Read MoreAfter the stress of the COVID-19 pandemic, a new national survey called the Inaugural...
Read More